Tempo Therapeutics
A regenerative-medicine company developing injectable microporous scaffolds that help the body rebuild tissue at damaged sites.
$14.5MFunding
ParticipantMV
Mesa Verde Venture Partners
Activity from announced rounds
Activity in this selectionOct 16, 2026 · Jul 19, 2026
Mesa Verde Venture Partners is the venture organization identified in Acurion and Tempo financing coverage.
Recorded funding activity
Acurion analyzes pathology images for cancer biomarkers. Tempo develops injectable scaffolds intended to support tissue regeneration. The company records distinguish diagnostic software from regenerative-medicine development.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $14.5M 1 disclosed · full round size, not this investor’s share